Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Responding to AF: Pill-in-Pocket Anticoagulation Guided by Automated Monitoring and Alerts [NA]
A clinical trial evaluating pill-in-pocket anticoagulation for atrial fibrillation, guided by automated monitoring and alerts, is currently …
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins [NA]
The document reports ongoing recruitment for a clinical trial examining whether statin therapy influences the occurrence of postoperative at…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: AF Burden and Echo-guided Persistent AF Ablation Strategy Using Either PV Isolation Alone (CLOSE Protocol) or Optimized Compartmentalization of the Left Atrium (Pseudo-maze Technique) [NA]
This completed clinical trial compares two echo-guided ablation strategies for persistent atrial fibrillation—PV isolation alone (CLOSE Prot…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
MONITOR-AF evaluated dynamic, data-driven management of atrial fibrillation using implantable cardiac monitors. The study has completed with…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: The Norwegian Exercise in Atrial Fibrillation Trial [NA]
This clinical trial update indicates that the Norwegian Exercise in Atrial Fibrillation trial (NCT05164718) is currently ACTIVE_NOT_RECRUITI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Mobile Individual Atrial Fibrillation Management Program [NA]
An update on the Mobile Individual Atrial Fibrillation Management Program trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study
A prospective cohort trial exploring optimized radiation dosing and wearable device monitoring to lower arrhythmia risk in patients undergoi…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
A clinical trial update for Tulane iPredict, Prevent Study evaluating the progression of atrial myopathy in patients with atrial fibrillatio…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Electronic Blood Pressure Monitor for Atrial Fibrillation Detection [NA]
This clinical trial update describes a study evaluating an electronic blood pressure monitor for detecting atrial fibrillation, with the tri…
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
-
FDA label_change · 2025-04-16FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for Cardizem CD (diltiazem hydrochloride) by Bausch Health US LLC.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AF [NA]
Clinical trial evaluating PVI alone versus PVI with posterior wall isolation for pulse-field ablation in persistent atrial fibrillation; sta…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Circumferential Pulmonary Vein Isolation Plus Transition Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas [NA]
A clinical trial update describes a study evaluating circumferential pulmonary vein isolation plus transition zone modification in atrial fi…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Cardiac Denervation in Aortic Arch Replacement [NA]
This clinical trial update describes a study on cardiac denervation during aortic arch replacement for patients with atrial fibrillation, an…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation [NA]
This clinical trial compares conduction system pacing versus biventricular pacing after atrioventricular node ablation in patients with hear…
-
FDA approval · 2025-04-14FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Digoxin submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
The document reports that a clinical trial studying the relationship between panic attack symptoms and paroxysmal atrial fibrillation has be…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. [NA]
RESOLVE-AF is a clinical evaluation of Cortex's Ablacath Mapping Catheter and Ablamap System using electrographic flow mapping to identify e…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
Completed clinical trial evaluating the safety of edoxaban in elderly patients with frailty criteria for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: A Feasibility Study for Elective Cardioversion of Atrial Fibrillation at Home [NA]
This completed feasibility trial evaluated whether elective cardioversion of atrial fibrillation can be performed at home using electric cou…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: From the Emergency Department Directly to Ablation of Atrial Fibrillation Study [NA]
A clinical trial is evaluating whether atrial fibrillation ablation can be performed directly after emergency department presentation. The s…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department [Phase 4]
Phase 4 trial comparing vernakalant versus procainamide for acute atrial fibrillation in the emergency department has completed. The study i…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
A registry study evaluating electrographic flow mapping in patients undergoing ablation for atrial fibrillation has completed recruitment an…